AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2010
May 27, 2010
34519_dirs_2010-05-27_b1f15027-9c0a-4bb4-ab24-7329af2b7dd0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2010-05-25
Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-05-25 | Common Stock, par value $0.10 per share | P | 200 | $3.35 | Acquired | 461650 | Direct |
| 2010-05-25 | Common Stock, par value $0.10 per share | P | 300 | $3.30 | Acquired | 461950 | Direct |
| 2010-05-26 | Common Stock, par value $0.10 per share | P | 400 | $3.3472 | Acquired | 462350 | Direct |
Footnotes
F1: These shares were acquired by Arterio, Inc., a company solely owned by Mr. Rothschild.
F2: This figure includes 214,155 shares of common stock held by Arterio, Inc., a company solely owned by Mr. Rothschild.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23